These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3498751)

  • 1. Selective down modulation of L3T4 molecules on murine thymocytes by the tumor promoter, phorbol 12-myristate 13-acetate.
    Wang PT; Bigby M; Sy MS
    J Immunol; 1987 Oct; 139(7):2157-65. PubMed ID: 3498751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirements for modulation of the CD4 molecule in response to phorbol myristate acetate. Role of the cytoplasmic domain.
    Sleckman BP; Bigby M; Greenstein JL; Burakoff SJ; Sy MS
    J Immunol; 1989 Mar; 142(5):1457-62. PubMed ID: 2783943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phorbol myristate acetate-induced down-modulation of CD4 is dependent on calmodulin and intracellular calcium.
    Bigby M; Wang P; Fierro JF; Sy MS
    J Immunol; 1990 Apr; 144(8):3111-6. PubMed ID: 2109010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of interleukin 4 receptor expression on immature (Lyt-2-/L3T4-) thymocytes.
    Lowenthal JW; Ransom J; Howard M; Zlotnik A
    J Immunol; 1988 Jan; 140(2):474-8. PubMed ID: 3257239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of interleukin 1 in early T cell development: Lyt-2-L3T4- thymocytes bind and respond in vitro to recombinant IL 1.
    Howe RC; Lowenthal JW; MacDonald HR
    J Immunol; 1986 Nov; 137(10):3195-200. PubMed ID: 2945862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developmental sequence of T200 antigen modifications in murine T cells.
    Lefrancois L; Goodman T
    J Immunol; 1987 Dec; 139(11):3718-24. PubMed ID: 2960741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional regulation of CD6 expression on human T lymphocytes by phorbol ester.
    Bott CM; Doshi JB; Li LL; McMurtry SA; Sanders JL; Fox DA
    J Immunol; 1994 Jul; 153(1):1-9. PubMed ID: 8207228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferation in vitro and interleukin production by 14 day fetal and adult Lyt-2-/L3T4- mouse thymocytes.
    Ceredig R
    J Immunol; 1986 Oct; 137(7):2260-7. PubMed ID: 3093570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic analysis of thymocytes that express homing receptors for peripheral lymph nodes.
    Reichert RA; Weissman IL; Butcher EC
    J Immunol; 1986 May; 136(10):3521-8. PubMed ID: 3084632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered expression of lymphocyte differentiation antigens on phorbol ester-activated CD4+8+ T cells.
    Richie ER; McEntire B; Phillips J; Allison JP
    J Immunol; 1988 Jun; 140(12):4115-22. PubMed ID: 3259607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Pgp-1 (or Ly24) by subpopulations of mouse thymocytes and activated peripheral T lymphocytes.
    Lynch F; Chaudhri G; Allan JE; Doherty PC; Ceredig R
    Eur J Immunol; 1987 Jan; 17(1):137-40. PubMed ID: 3102251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal expression of T cell receptor genes in Lyt-2- L3T4- lymphocytes of lpr mice: comparison with normal immature thymocytes.
    Miescher GC; Budd RC; Lees RK; MacDonald HR
    J Immunol; 1987 Mar; 138(6):1959-67. PubMed ID: 3102607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymic stroma-derived T cell growth factor (TSTGF). IV. Capacity of TSTGF to promote the growth of L3T4- Lyt-2- thymocytes by synergy with phorbol myristate acetate or various IL.
    Mizushima Y; Saitoh M; Ogata M; Kosaka H; Tatsumi Y; Kiyotaki C; Hamaoka T; Fujiwara H
    J Immunol; 1989 Feb; 142(4):1195-202. PubMed ID: 2783707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of immature (Lyt-2-/L3T4-) thymocytes. Identification of four major phenotypically distinct subsets differing in cell cycle status and in vitro activation requirements.
    Howe RC; MacDonald HR
    J Immunol; 1988 Feb; 140(4):1047-55. PubMed ID: 3257768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitogenic effect of PMA + IL 2 on subpopulations of corticoresistant thymocytes.
    Dupuy d'Angeac A; Monis M; Rème T
    J Immunol; 1986 Dec; 137(11):3501-8. PubMed ID: 3097124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposite CD4/CD8 lineage decisions of CD4+8+ mouse and rat thymocytes to equivalent triggering signals: correlation with thymic expression of a truncated CD8 alpha chain in mice but not rats.
    Mitnacht R; Bischof A; Torres-Nagel N; Hünig T
    J Immunol; 1998 Jan; 160(2):700-7. PubMed ID: 9551905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirements for growth of immature thymocytes from fetal and adult mice in vitro.
    Palacios R; Von Boehmer H
    Eur J Immunol; 1986 Jan; 16(1):12-9. PubMed ID: 3081352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of CD4 and CD8 expression on mouse T cells. Active removal from the cell surface by two mechanisms.
    Anderson SJ; Coleclough C
    J Immunol; 1993 Nov; 151(10):5123-34. PubMed ID: 8228214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of protein kinase C rapidly down-regulates naloxone-resistant receptors for beta-endorphin on U937 cells.
    Shahabi NA; Sharp BM
    J Pharmacol Exp Ther; 1993 Jan; 264(1):276-81. PubMed ID: 8380863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotype and localization of thymocytes expressing the homing receptor-associated antigen MEL-14: arguments for the view that most mature thymocytes are located in the medulla.
    Shortman K; Wilson A; Van Ewijk W; Scollay R
    J Immunol; 1987 Jan; 138(2):342-51. PubMed ID: 3491849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.